# Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes

> **NCT00598013** · NA · COMPLETED · sponsor: **Yonsei University** · enrollment: 83 (actual)

## Conditions studied

- Kidney Transplantation
- Insulin Resistance
- Atherosclerosis

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT00598013
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2008-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00598013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00598013, "Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00598013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*